Merck Painkiller Trials Will Continue ; Panel Oks Studies of Sequel to Vioxx
The Record, Bergen County, NJ › June 20, 2005
Linked as:
Summary
Merck & Co. said Friday that its experimental Arcoxia painkiller, a follow-up to its withdrawn Vioxx drug, was cleared for further clinical study by an independent safety monitoring board.
A board responsible for overseeing safety of two clinical trials of Arcoxia recently recommended that the trials continue, Merck said in a statement.See the full content of this document
Extract
Merck Painkiller Trials Will Continue ; Panel Oks Studies of Sequel to Vioxx
The trials involve more than 27,000 arthritis and rheumatoid patients and compare ...
See the full content of this document
Sponsored links
